Literature DB >> 20098229

Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines.

Dawn I Velligan1, Peter J Weiden, Martha Sajatovic, Jan Scott, Daniel Carpenter, Ruth Ross, John P Docherty.   

Abstract

Poor adherence to medication treatment can have devastating consequences for patients with serious mental illness. The literature review and recommendations in this article concerning assessment of adherence are reprinted from The Expert Consensus Guideline Series: Adherence Problems in Patients with Serious and Persistent Mental Illness, published in 2009. The expert consensus survey contained 39 questions (521 options) that asked about defining nonadherence, extent of adherence problems in schizophrenia and bipolar disorder, risk factors for nonadherence, assessment methods, and interventions for specific types of adherence problems. The survey was completed by 41 (85%) of the 48 experts to whom it was sent. When evaluating adherence, the experts considered it important to assess both behavior and attitude, although they considered actual behavior most important. They also noted the importance of distinguishing patients who are not willing to take medication from those who are willing but not able to take their medication as prescribed due to forgetfulness, misunderstanding of instructions, or financial or environmental problems, since this will affect the type of intervention needed. Although self- and physician report are most commonly used to clinically assess adherence, they are often inaccurate and may underestimate nonadherence. The experts believe that more accurate information will be obtained by asking about any problems patients are having or anticipate having taking medication rather than if they have been taking their medication; They also recommended speaking with family or caregivers, if the patient gives permission, as well as using more objective measures (e.g., pill counts, pharmacy records, smart pill containers if available, and, when appropriate, medication plasma levels). Use of a validated self-report scale may also help improve accuracy. For patients who appear adherent to medication, the experts recommended monthly assessments for adherence, with additional assessments if there is a noticeable symptomatic change. If there is concern about adherence, they recommended more frequent (e.g., weekly) assessments. The article concludes with suggestions for clinical interview techniques for assessing adherence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20098229     DOI: 10.1097/01.pra.0000367776.96012.ca

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  34 in total

Review 1.  Self-report measures of medication adherence behavior: recommendations on optimal use.

Authors:  Michael J Stirratt; Jacqueline Dunbar-Jacob; Heidi M Crane; Jane M Simoni; Susan Czajkowski; Marisa E Hilliard; James E Aikens; Christine M Hunter; Dawn I Velligan; Kristen Huntley; Gbenga Ogedegbe; Cynthia S Rand; Eleanor Schron; Wendy J Nilsen
Journal:  Transl Behav Med       Date:  2015-07-09       Impact factor: 3.046

2.  Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder.

Authors:  Daniel J Coletti; Elizabeth Pappadopulos; Nikki J Katsiotas; Alison Berest; Peter S Jensen; Vivian Kafantaris
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-04-26       Impact factor: 2.576

Review 3.  Medication adherence in schizophrenia.

Authors:  Francisco Javier Acosta; José Luis Hernández; José Pereira; Judit Herrera; Carlos J Rodríguez
Journal:  World J Psychiatry       Date:  2012-10-22

4.  Comparison of immigrant and native-born population adherence to antipsychotic treatment in a Spanish health region.

Authors:  Irene Forcada; Vanessa Pera; Inés Cruz; Josep Pifarre; Pifarré Josep; Catalina Serna; Montserrat Rué; Leonardo Galván
Journal:  Community Ment Health J       Date:  2012-09-29

5.  How clients solicit medication changes in psychiatry.

Authors:  Galina B Bolden; Beth Angell; Alexa Hepburn
Journal:  Sociol Health Illn       Date:  2019-01-22

6.  Measuring adherence to antipsychotic medications for schizophrenia: Concordance and validity among a community sample in rural China.

Authors:  Dong Roman Xu; Wenjie Gong; Steve Gloyd; Eric D Caine; Jane Simoni; James P Hughes; Shuiyuan Xiao; Wenjun He; Bofeng Dai; Meijuan Lin; Juan Nie; Hua He
Journal:  Schizophr Res       Date:  2018-05-26       Impact factor: 4.939

7.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

8.  Hospitalization and Some Sociodemographic Characteristics of Patients Registered with a Community Mental Health Center.

Authors:  Etem Erdal Erşan
Journal:  Community Ment Health J       Date:  2019-11-16

9.  Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone.

Authors:  Rosa Ayesa-Arriola; Jose Manuel Rodríguez-Sánchez; Rocío Pérez-Iglesias; Roberto Roiz-Santiáñez; Obdulia Martínez-García; Jose Sánchez-Moreno; Rafael Tabarés-Seisdedos; Jose L Vázquez-Barquero; Benedicto Crespo-Facorro
Journal:  Psychopharmacology (Berl)       Date:  2013-03-02       Impact factor: 4.530

10.  Developing a Community-Based Tailored Exercise Program for People With Severe and Persistent Mental Illness.

Authors:  Kamden D Hoffmann; Adrienne Walnoha; Jennifer Sloan; Praewpannarai Buddadhumaruk; Hsin-Hui Huang; Jeffrey Borrebach; Patricia A Cluss; Jessica G Burke
Journal:  Prog Community Health Partnersh       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.